Results 21 to 30 of about 163,168 (216)

Carbapenem resistant Campylobacter jejuni bacteremia in a Bruton's X-linked agammaglobulinemia patient. [PDF]

Eur J Clin Microbiol Infect Dis
Immunocompromised patients are prone to recurrent Campylobacter infections. We report a case of recurrent multi-drug resistant Campylobactor jejuni bloodstream infections in a Bruton’s X-linked agammaglobulinemia patient with prolonged ertapenem ...
Zhuo R, Younes RL, Ward K, Yang S.
europepmc   +2 more sources

Pulmonary alveolar proteinosis induced by X-linked agammaglobulinemia: A case report. [PDF]

World J Clin Cases
BACKGROUND Pulmonary alveolar proteinosis (PAP) and X-linked agammaglobulinemia (XLA) are rare diseases in children. Many theories infer that immunodeficiency can induce PAP, but these reports are almost all review articles, and there is little clinical ...
Zhang T, Li M, Tan L, Li X.
europepmc   +2 more sources

The Clinical Course of COVID-19 Pneumonia in a 19-Year-Old Man on Intravenous Immunoglobulin Replacement Therapy for X-Linked Agammaglobulinemia

The American journal of case reports, 2021
Patient: Male, 19-year-old Final Diagnosis: COVID-19 Symptoms: Cough • diarrhea • fever • shortness of breath Medication: — Clinical Procedure: — Specialty: Immunology • Infectious Diseases • Pulmonology Objective: Rare co-existance of disease or ...
Ali Almontasheri, Faisal Al-Husayni, Anas Alsuraihi, Hanan Binyahib, Amr S. Albanna   +4 more
openalex   +2 more sources

Autoimmunity and Inflammation in X-linked Agammaglobulinemia [PDF]

Journal of Clinical Immunology, 2014
In the past, XLA was described as associated with several inflammatory conditions, but with adequate immune globulin treatment, these are presumed to have diminished. The actual prevalence is not known.A web-based patient survey was conducted December 2011- February 2012.
Vivian Hernandez‐Trujillo, Chris Scalchunes, Charlotte Cunningham‐Rundles, Hans D. Ochs, Francisco A. Bonilla, K. Paris, Leman Yel, Kathleen E. Sullivan   +7 more
openalex   +6 more sources

Revisiting X-linked agammaglobulinemia

Journal of Human Immunity
Discovered >70 years ago by Ogden Bruton, X-linked agammaglobulinemia (XLA), characterized by recurrent bacterial infections, hypo/agammaglobulinemia, and peripheral blood B-cell deficiency, is among the best-established inborn errors of immunity (IEIs) and one of the most well-documented single types of IEIs, the incidence of which is estimated
Hirokazu Kanegane, Kay Tanita, Madoka Nishimura, Dan Tomomasa, Kento Inoue, Toru Kanamori, Akira Nishimura, Hans D. Ochs   +7 more
openaire   +2 more sources

COVID-19 and X-linked agammaglobulinemia (XLA) – insights from a monogenic antibody deficiency

Current Opinion in Allergy and Clinical Immunology, 2021
Purpose of review The clinical outcomes from COVID-19 in monogenic causes of predominant antibody deficiency have pivotal implications for our understanding of the antiviral contribution of humoral immunity.
Mark J Ponsford, Ian R Humphreys, Andrew Gennery   +2 more
exaly   +2 more sources

Gastric adenocarcinoma in a patient with X-linked agammaglobulinemia and HIV: Case report and review of the literature [PDF]

Frontiers in Pediatrics, 2016
X-linked agammaglobulinemia (XLA) is an X-linked inherited disease usually caused by a germline mutation in the BTK gene leading to Bruton’s tyrosine kinase deficiency, which results in the impaired development of B-lymphocytes and a subsequent lack of ...
Joud Hajjar, Sana Hasan, Lisa Renee Forbes, Vagish Hemmige, Jordan Scott Orange   +4 more
doaj   +2 more sources

Naïve Regulatory T Cell Subset Is Altered in X-Linked Agammaglobulinemia [PDF]

Frontiers in Immunology, 2021
The interplay between T- and B-cell compartments during naïve, effector and memory T cell maturation is critical for a balanced immune response. Primary B-cell immunodeficiency arising from X-linked agammaglobulinemia (XLA) offers a model to explore B ...
Pavel V. Shelyakin, Ksenia R. Lupyr, Ksenia R. Lupyr, Evgeny S. Egorov, Ilya A. Kofiadi, Dmitriy B. Staroverov, Dmitriy B. Staroverov, Sofya A. Kasatskaya, Sofya A. Kasatskaya, Sofya A. Kasatskaya, Valeriia V. Kriukova, Valeriia V. Kriukova, Irina A. Shagina, Irina A. Shagina, Ekaterina M. Merzlyak, Ekaterina M. Merzlyak, Tatiana O. Nakonechnaya, Elena A. Latysheva, Irina A. Manto, Musa R. Khaitov, Sergey A. Lukyanov, Dmitriy M. Chudakov, Dmitriy M. Chudakov, Dmitriy M. Chudakov, Olga V. Britanova   +24 more
doaj   +2 more sources

SARS-CoV-2 spike antibody concentration in gamma globulin products from high-prevalence COVID-19 countries are transmitted to X-linked agammaglobulinemia patients. [PDF]

Front Immunol, 2023
Purpose Patients with X-linked agammaglobulinemia (XLA) are characterized by humoral impairment and are routinely treated with intravenous immunoglobulin (IVIG).
Raphael A, Shamriz O, Tvito A, Magen S, Goldberg S, Megged O, Lev A, Simon AJ, Tal Y, Somech R, Eisenberg R, Toker O.   +11 more
europepmc   +2 more sources

Mycoplasma pneumonia in a patient with X-linked agammaglobulinemia [PDF]

BMC Infectious Diseases
Background X-linked agammaglobulinemia (XLA), also referred to as Bruton’s tyrosine kinase deficiency, is a rare genetic disorder that affects the immune system.
Bowen Dai, Shujuan Han, Yuanfang Shen, Zhi Li, Shouhang Chen, Zhuangzhuang Wang, Yan Yuan, Ruyu Zhang, Chenyu Wang, Jiaying Zheng, Qiujing Liang, Qingmei Wang, Yaodong Zhang, Xiaolong Zhang, Fang Wang, Yuefei Jin   +15 more
doaj   +2 more sources